Cointime

Maverick Therapeutics

company

About

Maverick Therapeutics is a biotech company focused on improving the lives of patients with solid tumor cancers

  • 10001 - max

Highlights

Total Funding Amount
$125M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$125M
Industries
Biotechnology
Founded date
Jan 1, 2016
Number Of Employee
10001 - max
Operating Status
Active

Maverick Therapeutics is a biotech company focused on improving the lives of patients with solid tumor cancers by developing breakthrough T cell immunotherapies with improved safety and efficacy. Their highly innovative platform, COBRA™, is the most advanced bispecific T cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$125M
Maverick Therapeutics has raised a total of $125M in funding over 2 rounds. Their latest funding was raised on Jan 1, 2017 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2017 Series Unknown $125M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Maverick Therapeutics is funded by 1 investors. Takeda are the most recent investors.
Investor Name Lead Investor Funding Round
Takeda — Series Unknown
Cointime
เนื้อหา
บริษัท